Projects per year
Fingerprint
Profiles
-
Maureen Aarts - Essers
- Faculty of Health, Medicine and Life Sciences, Oncology - Associate Professor
- MA Medische Oncologie - Medical Specialist
- GROW - Innovative Cancer Diagnostics & Therapy
Person: Paid Staff - Academic Staff, Paid Staff - azM-employee, Unpaid Staff - Academic Staff AZM
-
Monique Abhelakh
- MA Med Staf Artsass Cardiologie - PhD MUMC+
- MA Med Staf Artsass Interne Geneeskunde - PhD MUMC+
Person: Paid Staff - azM-employee
Projects
- 1 Finished
-
Mechanistic Integration of vascular aND endocrine pathways for Subtyping Hypertension: an Innovative network approach for Future generation research Training
Unger, T. (Primary Investigator), Reesink, K. (Primary Investigator), Foulquier, S. (Co-Investigators), Stehouwer, C. (Co-Investigators), van Greevenbroek, M. (Co-Investigators), Houben, B. (Co-Investigators), Schalkwijk, C. (Co-Investigators), Isaacs, A. (Co-Investigators), Kroon, B. (Co-Investigators) & Schurgers, L. (Co-Investigators)
1/01/21 → 31/12/24
Project: Research
Research output
-
Activated FXI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in non-small cell lung cancer patients
Gomez-Rosas, P., Nagy, M., Spronk, H. M. H., Russo, L., Gamba, S., Tartari, C. J., Bolognini, S., Ticozzi, C., Schieppati, F., Sarmiento, R., De Braud, F., Masci, G., Tondini, C., Petrelli, F., Giuliani, F., D'Alessio, A., Santoro, A., Gasparini, G., Labianca, R. & Cate, H. T. & 3 others, , 2025, (E-pub ahead of print) In: Journal of Thrombosis and Haemostasis.Research output: Contribution to journal › Article › Academic › peer-review
-
Activation of the HPA axis does not explain non-responsiveness to GLP-1R agonist treatment in individuals with type 2 diabetes
Tokgöz, S., Boss, M., Jansen, T. J., Meijer, R., Frielink, C., van Bon, A. C., Tack, C. J., de Galan, B. E. & Gotthardt, M., 1 Feb 2025, In: Diabetes. 74, 2, p. 212-222 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis
Bloem, M., de Meza, M. M., van den Eertwegh, A. J. M., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Blokx, W. A. M., Boers-Sonderen, M. J., Bonenkamp, J. J., Boreel, C. D. M., de Groot, J. W. B., Haanen, J. B. A. G., Hospers, G. A. P., Kapiteijn, E., van Not, O. J., Piersma, D., Rikhof, B., Stevense-den Boer, A. M., van der Veldt, A. A. M. & Vreugdenhil, G. & 2 others, , 1 Apr 2025, (E-pub ahead of print) In: British Journal of Cancer. 7 p., 102290.Research output: Contribution to journal › Article › Academic › peer-review
Activities
- 1 Inaugural speech
-
Niet alleen met medicatie
Kroon, B. (Speaker)
13 Jan 2017Activity: Talk or presentation / Performance / Speeches › Inaugural speech › Popular
Press/Media
-
No Benefit to Add-on Antiplatelet Therapy in Moderate Covid-19
19/01/22
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
-
Does Prediabetes Matter?
Stehouwer, C.
16/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular